Literature DB >> 29362227

Down Syndrome Critical Region 1 Gene, Rcan1, Helps Maintain a More Fused Mitochondrial Network.

Valentina Parra1, Francisco Altamirano2, Carolina P Hernández-Fuentes2, Dan Tong2, Victoriia Kyrychenko2, David Rotter2, Zully Pedrozo2, Joseph A Hill2, Verónica Eisner2, Sergio Lavandero2, Jay W Schneider2, Beverly A Rothermel1.   

Abstract

RATIONALE: The regulator of calcineurin 1 (RCAN1) inhibits CN (calcineurin), a Ca2+-activated protein phosphatase important in cardiac remodeling. In humans, RCAN1 is located on chromosome 21 in proximity to the Down syndrome critical region. The hearts and brains of Rcan1 KO mice are more susceptible to damage from ischemia/reperfusion (I/R); however, the underlying cause is not known.
OBJECTIVE: Mitochondria are key mediators of I/R damage. The goal of these studies was to determine the impact of RCAN1 on mitochondrial dynamics and function. METHODS AND
RESULTS: Using both neonatal and isolated adult cardiomyocytes, we show that, when RCAN1 is depleted, the mitochondrial network is more fragmented because of increased CN-dependent activation of the fission protein, DRP1 (dynamin-1-like). Mitochondria in RCAN1-depleted cardiomyocytes have reduced membrane potential, O2 consumption, and generation of reactive oxygen species, as well as a reduced capacity for mitochondrial Ca2+ uptake. RCAN1-depleted cardiomyocytes were more sensitive to I/R; however, pharmacological inhibition of CN, DRP1, or CAPN (calpains; Ca2+-activated proteases) restored protection, suggesting that in the absence of RCAN1, CAPN-mediated damage after I/R is greater because of a decrease in the capacity of mitochondria to buffer cytoplasmic Ca2+. Increasing RCAN1 levels by adenoviral infection was sufficient to enhance fusion and confer protection from I/R. To examine the impact of more modest, and biologically relevant, increases in RCAN1, we compared the mitochondrial network in induced pluripotent stem cells derived from individuals with Down syndrome to that of isogenic, disomic controls. Mitochondria were more fused, and O2 consumption was greater in the trisomic induced pluripotent stem cells; however, coupling efficiency and metabolic flexibility were compromised compared with disomic induced pluripotent stem cells. Depletion of RCAN1 from trisomic induced pluripotent stem cells was sufficient to normalize mitochondrial dynamics and function.
CONCLUSIONS: RCAN1 helps maintain a more interconnected mitochondrial network, and maintaining appropriate RCAN1 levels is important to human health and disease.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  Down syndrome; calcineurin; calpain; ischemia reperfusion injury; mitochondria; mitochondrial dynamics

Mesh:

Substances:

Year:  2018        PMID: 29362227      PMCID: PMC5924463          DOI: 10.1161/CIRCRESAHA.117.311522

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  51 in total

1.  Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion.

Authors:  Víctor Hernando; Javier Inserte; Carmem Luíza Sartório; Víctor M Parra; Marcos Poncelas-Nozal; David Garcia-Dorado
Journal:  J Mol Cell Cardiol       Date:  2010-03-06       Impact factor: 5.000

Review 2.  New insights into the function and regulation of mitochondrial fission.

Authors:  Hidenori Otera; Naotada Ishihara; Katsuyoshi Mihara
Journal:  Biochim Biophys Acta       Date:  2013-02-20

3.  Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress.

Authors:  D R Crawford; K P Leahy; N Abramova; L Lan; Y Wang; K J Davies
Journal:  Arch Biochem Biophys       Date:  1997-06-01       Impact factor: 4.013

Review 4.  Mitochondrial injury and protection in ischemic pre- and postconditioning.

Authors:  Fabio Di Lisa; Marcella Canton; Andrea Carpi; Nina Kaludercic; Roberta Menabò; Sara Menazza; Martina Semenzato
Journal:  Antioxid Redox Signal       Date:  2010-11-30       Impact factor: 8.401

5.  A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.

Authors:  Andrew P Halestrap
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

6.  The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress.

Authors:  Gennady Ermak; Cathryn D Harris; Kelvin J A Davies
Journal:  FASEB J       Date:  2002-06       Impact factor: 5.191

7.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

Review 8.  The on-off switches of the mitochondrial uncoupling proteins.

Authors:  Vian Azzu; Martin D Brand
Journal:  Trends Biochem Sci       Date:  2009-12-16       Impact factor: 13.807

9.  Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis.

Authors:  Valentina Parra; Veronica Eisner; Mario Chiong; Alfredo Criollo; Francisco Moraga; Alejandra Garcia; Steffen Härtel; Enrique Jaimovich; Antonio Zorzano; Cecilia Hidalgo; Sergio Lavandero
Journal:  Cardiovasc Res       Date:  2007-10-04       Impact factor: 10.787

10.  Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL.

Authors:  Seok Min Jin; Michael Lazarou; Chunxin Wang; Lesley A Kane; Derek P Narendra; Richard J Youle
Journal:  J Cell Biol       Date:  2010-11-29       Impact factor: 10.539

View more
  20 in total

Review 1.  Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases?

Authors:  Alexis Diaz-Vegas; Pablo Sanchez-Aguilera; James R Krycer; Pablo E Morales; Matías Monsalves-Alvarez; Mariana Cifuentes; Beverly A Rothermel; Sergio Lavandero
Journal:  Endocr Rev       Date:  2020-06-01       Impact factor: 19.871

2.  Restoration of Cardiomyogenesis in Aged Mouse Hearts by Voluntary Exercise.

Authors:  Carolin Lerchenmüller; Ana Vujic; Anthony Rosenzweig; Richard T Lee; Sonja Mittag; Annie Wang; Charles P Rabolli; Chiara Heß; Fynn Betge; Ashraf Y Rangrez; Malay Chaklader; Christelle Guillermier; Frank Gyngard; Jason D Roh; Haobo Li; Matthew L Steinhauser; Norbert Frey; Beverly Rothermel; Christoph Dieterich
Journal:  Circulation       Date:  2022-07-06       Impact factor: 39.918

3.  Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer's Disease.

Authors:  Sandra Espinoza; Felipe Grunenwald; Wileidy Gomez; Felipe García; Lorena Abarzúa-Catalan; Sebastián Oyarce-Pezoa; Maria Fernanda Hernandez; Bastián I Cortés; Markus Uhrig; Daniela P Ponce; Claudia Durán-Aniotz; Claudio Hetz; Carol D SanMartín; Victor H Cornejo; Fernando Ezquer; Valentina Parra; Maria Isabel Behrens; Patricio A Manque; Diego Rojas-Rivera; René L Vidal; Ute Woehlbier; Melissa Nassif
Journal:  Cells       Date:  2022-06-07       Impact factor: 7.666

4.  Regulator of Calcineurin 1 helps coordinate whole-body metabolism and thermogenesis.

Authors:  David Rotter; Heshan Peiris; D Bennett Grinsfelder; Alyce M Martin; Jana Burchfield; Valentina Parra; Christi Hull; Cyndi R Morales; Claire F Jessup; Dusan Matusica; Brian W Parks; Aldons J Lusis; Ngoc Uyen Nhi Nguyen; Misook Oh; Israel Iyoke; Tanvi Jakkampudi; D Randy McMillan; Hesham A Sadek; Matthew J Watt; Rana K Gupta; Melanie A Pritchard; Damien J Keating; Beverly A Rothermel
Journal:  EMBO Rep       Date:  2018-11-02       Impact factor: 8.807

Review 5.  Molecular link between circadian clocks and cardiac function: a network of core clock, slave clock, and effectors.

Authors:  Weiyi Xu; Mukesh K Jain; Lilei Zhang
Journal:  Curr Opin Pharmacol       Date:  2020-11-12       Impact factor: 5.547

6.  Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society.

Authors:  Mara Dierssen; Yann Herault; Pablo Helguera; Maria Martínez de Lagran; Anna Vazquez; Bradley Christian; Maria Carmona-Iragui; Frances Wiseman; William Mobley; Elizabeth M C Fisher; Veronique Brault; Anna Esbensen; Lisa M Jacola; Marie Claude Potier; Eric D Hamlett; Leonard Abbeduto; Laura Del Hoyo Soriano; Jorge Busciglio; Maria Florencia Iulita; John Crispino; Sébastien Malinge; Eugenio Barone; Marzia Perluigi; Floriana Costanzo; Jean Maurice Delabar; Renata Bartesaghi; Alain D Dekker; Peter De Deyn; Juan Fortea Ormaechea; Patricia A Shaw; Tarik F Haydar; Stephanie L Sherman; André Strydom; Anita Bhattacharyya
Journal:  Mol Syndromol       Date:  2021-05-20

7.  NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction.

Authors:  Dan Tong; Gabriele G Schiattarella; Nan Jiang; Francisco Altamirano; Pamela A Szweda; Abdallah Elnwasany; Dong I Lee; Heesoo Yoo; David A Kass; Luke I Szweda; Sergio Lavandero; Eric Verdin; Thomas G Gillette; Joseph A Hill
Journal:  Circ Res       Date:  2021-04-22       Impact factor: 23.213

Review 8.  Regulator of Calcineurin (RCAN): Beyond Down Syndrome Critical Region.

Authors:  Sun-Kyung Lee; Joohong Ahnn
Journal:  Mol Cells       Date:  2020-08-31       Impact factor: 5.034

9.  Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture.

Authors:  Silvia Villahoz; Paula Sofía Yunes-Leites; Nerea Méndez-Barbero; Katia Urso; Elena Bonzon-Kulichenko; Sagrario Ortega; J Francisco Nistal; Jesus Vazquez; Stefan Offermanns; Juan Miguel Redondo; Miguel R Campanero
Journal:  Nat Commun       Date:  2018-11-15       Impact factor: 14.919

10.  Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function.

Authors:  Soo Young Kim; Xin Zhang; Gabriele G Schiattarella; Francisco Altamirano; Thais A R Ramos; Kristin M French; Nan Jiang; Pamela A Szweda; Bret M Evers; Herman I May; Xiang Luo; Hongliang Li; Luke I Szweda; Vinicius Maracaja-Coutinho; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2020-10-28       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.